Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study

Jelena Pavlovic; Maryam Kavousi; Arfan Ikram; Maarten Leening

doi:10.1016/j.atherosclerosis.2020.02.020

Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study

Jelena Pavlovic, Maryam Kavousi, Arfan Ikram, Maarten Leening

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

38 Downloads (Pure)

Original language	English
Pages (from-to)	64-66
Number of pages	3
Journal	Atherosclerosis
Volume	299
DOIs	https://doi.org/10.1016/j.atherosclerosis.2020.02.020
Publication status	Published - 2020

Research programs

EMC NIHES-03-30-02
EMC OR-01

Access to Document

10.1016/j.atherosclerosis.2020.02.020

Repub_126295.pdfFinal published version, 1.18 MB

Cite this

@article{a032374cd8de484693bca194018ebf44,

title = "Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study",

author = "Jelena Pavlovic and Maryam Kavousi and Arfan Ikram and Maarten Leening",

year = "2020",

doi = "10.1016/j.atherosclerosis.2020.02.020",

language = "English",

volume = "299",

pages = "64--66",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study. / Pavlovic, Jelena ; Kavousi, Maryam ; Ikram, Arfan et al.
In: Atherosclerosis, Vol. 299, 2020, p. 64-66.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study

AU - Pavlovic, Jelena

AU - Kavousi, Maryam

AU - Ikram, Arfan

AU - Leening, Maarten

PY - 2020

Y1 - 2020

U2 - 10.1016/j.atherosclerosis.2020.02.020

DO - 10.1016/j.atherosclerosis.2020.02.020

M3 - Article

C2 - 32169303

SN - 0021-9150

VL - 299

SP - 64

EP - 66

JO - Atherosclerosis

JF - Atherosclerosis

ER -